@using Discoverx.Models;
@model Discoverx.Models.StudyReport.PHStudyReportViewModel

<table style="border:hidden;page-break-before:always">
    <tr>
        <td valign="top" class="no_border">

            <div>
                <p style='font-size:16pt;font-weight:bold; font-style:italic'>Assay Design: Cell Based Kinase
</p>
                <p class='sub-sub'>Cell Handling</p>
                <ol>
                    <li>
                        PathHunter cell lines were expanded from freezer stocks according to standard procedures.
                    </li>
                    <li>
                        Cells were seeded in a total volume of 20 µL into white walled, 384-well microplates and incubated for the appropriate time prior to testing.
                    </li>
                </ol>

                <p class='sub-sub'>
                    Agonist Format
                </p>
                <ol>
                    <li>
                        For agonist determination, cells were incubated with sample to induce response.
                    </li>

                    <li>
                        Intermediate dilution of sample stocks was performed to generate 5X sample in assay buffer.
                    </li>
                    <li>
                        5 µL of 5X sample was added to cells and incubated at 37°C or room temperature according to standard procedures.  Vehicle concentration was 1%.
                    </li>
                </ol>
                <p class='sub-sub'>
                    Antagonist Format
                </p>
                <p>For most assays, cells are pre-incubated with compound followed by EC80 agonist challenge as follows:</p>
                <ol>
                    
                    <li>
                        Intermediate dilution of sample stocks was performed to generate 5X sample in assay buffer.
                    </li>
                    <li>
                        5 µL of 5X sample was added to cells and incubated at 37°C for 60 minutes.  Vehicle concentration was 1%.
                    </li>
                    <li>
                        5 µL of 6X EC80 agonist in assay buffer was added to the cells and incubated at 37°C overnight.
                    </li>
                </ol>
                <p>For select assays (DDR1), cells are pre-incubated with compound followed by EC80 agonist challenge as follows:</p>
                <ol>
                    <li>
                        Cells were seeded and incubated for 2 hours.
                    </li>
                    <li>
                        Intermediate dilution of sample stocks was performed to generate 5X sample in assay buffer.
                    </li>
                    <li>
                        5 µL of 5X sample was added to cells and incubated at 37°C for 60 minutes.  Vehicle concentration was 1%.
                    </li>
                    <li>
                        5 µL of 6X EC80 agonist in assay buffer was added to the cells and incubated at 37°C overnight.
                    </li>
                </ol>
                <p class='sub-sub'>
                    Signal Detection
                </p>
                <ol>
                    <li>
                        Assay signal was generated through a single addition of 12.5 or 15 µL (50% v/v) of PathHunter Detection reagent cocktail for agonist and antagonist assays respectively,
                        followed by a one hour incubation at room temperature.
                    </li>
                    <li>
                        Microplates were read following signal generation with a PerkinElmer Envision<sup>TM</sup> instrument for chemilumine-scent signal detection.
                    </li>
                </ol>
                <p class='sub-sub'>
                    Data Analysis
                </p>
                <ol>
                    <li>
                        Compound activity was analyzed using CBIS data analysis suite (ChemInnovation, CA).
                    </li>
                    <li>
                        For agonist mode assays, percentage activity was calculated using the following formula:
                        <p>
                            % Activity =100% x (mean RLU of test sample - mean RLU of vehicle control) / (mean MAX RLU control ligand - mean RLU of vehicle control)
                        </p>
                    </li>
                    <li>
                        For antagonist mode assays, percentage inhibition was calculated using the following formula:

                        <p>
                            % Inhibition =100% x (1 - (mean RLU of test sample - mean RLU of vehicle control) / (mean RLU of EC80 control - mean RLU of vehicle control)).
                        </p>
                    </li>
                </ol>
                        </div>

        </td>
    </tr>

</table>


